InvestorsHub Logo
Followers 480
Posts 60305
Boards Moderated 18
Alias Born 09/20/2001

Re: None

Thursday, 10/22/2020 9:35:53 PM

Thursday, October 22, 2020 9:35:53 PM

Post# of 1106
November 6, 2020 8am Earnings CC

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, November 6, 2020 to discuss its third quarter operating results. Management will also provide a brief update on the business.

Conference Call Information

To access the live call by phone, dial (877) 621-5803; the conference ID is 9864218. The call may also be accessed through the Investors and Media section of the Company’s website, www.immunogen.com. Following the call, a replay will be available at the same location



https://finance.yahoo.com/news/immunogen-announces-conference-call-discuss-200100609.html?.tsrc=rss


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMGN News